Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap1.1B
Enterprise Value954.32M
P/E Ratio6.18
PEG Ratio0.68
Price/Sales Ratio1.36
Price/Book Ratio0.73
Enterprise/Revenue1.2
Enterprise/EBITDA3.69

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin0.22
Operating Margin0.29
AD

Management Effectiveness

Return On Assets0.07
Return On Equity0.12

Income Statement

Revenue901.87M
Revenue/Share1.61
Gross Profit757.67M
EBITDA294.19M
Net Income198.88M
Diluted EPS0.35

Balance Sheet

Total Cash681.45M
Total Cash/Share1.22
Total Debt400,000
Total Debt/Equity0
Current Ratio1.3
Book Value Per Share3.01

Price History

52-Week Change8.09
52-Week High3
52-Week Low1.82
Moving Average 50 Days2.46
Moving Average 200 Days2.23

Statistics

Average Volume97,833
Shares Outstanding560.17M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield11.34
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD